Market Cap
$19.46B$2.66B+15.84%
Summary
- Current Value
- As of today, MRNA market cap is $19B, up +15.84% in the most recent trading session on
- Category
- Based on its current market cap, MRNA falls into the large-cap category
- Historical Performance
- MRNA market cap is up +68.90% year-to-date, and up +40.49% over the past 365 days
- All-Time High Comparison
- MRNA market cap is currently -90.05% below its historical high of $196B set on
- 3-Year Low Comparison
- MRNA market cap is +122.76% above its 3-year low of $9B reached on
- Sector Comparison
- MRNA market cap is higher than 94.40% of companies in Healthcare sector
Market Cap Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1D | 1M | 3M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $19B | +15.8% | +47.4% | +81.3% | +68.9% | +40.5% | -73.9% | -63.3% | |
| Price | $49.81 | +15.8% | +47.4% | +81.2% | +68.9% | +38.8% | -74.3% | -62.5% | |
| Shares Outstanding | 390.73M | +0.0% | – | – | – | +1.2% | +1.5% | -2.0% | |
| PE Ratio | - | – | – | – | – | – | – | – | |
| TTM Revenue | $2.23B | -27.5% | – | -27.5% | – | -56.0% | -89.5% | +804.7% | |
| TTM EPS | -$8.06 | -7.3% | – | -7.3% | – | -38.4% | -129.2% | -397.1% | |
| Enterprise Value | $15.69B | +20.4% | +66.3% | +125.3% | +102.4% | +107.2% | -76.2% | -67.8% | |
| - | – | – | – | – | – | – | – | ||
| TTM Net Income | -$3.12B | -7.3% | – | -7.3% | – | -40.1% | -126.5% | -420.4% |
Market Cap Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1M | $19B | at high | |
| 3M | $19B | at high | |
| 6M | $19B | at high | |
| 1Y | $19B | at high | |
| 3Y | $76B | -74.3% | |
| 5Y | $196B | -90.0% | |
| All | $196B | -90.0% |
Market Cap Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1M | $12B | +68.9% | |
| 3M | $9B | +122.8% | |
| 6M | $9B | +122.8% | |
| 1Y | $9B | +122.8% | |
| 3Y | $9B | +122.8% | |
| 5Y | $9B | +122.8% | |
| All | $4B | +380.8% |
Market Cap History
| Date | Value | Change |
|---|---|---|
| $19B | +68.9% | |
| $12B | -28.2% | |
| $16B | -57.8% | |
| $38B | -45.1% | |
| $69B | -32.4% |
| Date | Value | Change |
|---|---|---|
| $102B | +145.7% | |
| $42B | +532.9% | |
| $7B | +31.1% | |
| $5B | - |
FAQ
What is the current market cap of MRNA?
As of today, MRNA market cap is $19B
What market cap category does MRNA fall into?
Based on its current market cap, MRNA falls into the large-cap category
What is MRNA market cap today change?
MRNA market cap is up +15.84% today
What is 1-year change in MRNA market cap?
MRNA market cap is up +40.49% year-over-year
How far is MRNA market cap from its all-time high?
MRNA market cap is currently -90.05% below its historical high of $196B set on August 9, 2021
How does MRNA market cap rank versus sector peers?
MRNA market cap is higher than 94.40% of companies in Healthcare sector
Market Cap Formula
Market Cap = Price × Shares Outstanding
Data Sources & References
- MRNA Official Website www.modernatx.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1682852/000168285225000075/0001682852-25-000075-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1682852/000168285225000022/0001682852-25-000022-index.htm
- MRNA Profile on Yahoo Finance finance.yahoo.com/quote/MRNA
- MRNA Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/mrna